Higher predicted expression levels of ZNF235 showed marginal significant associations with lower ALS risk in the brain caudate tissue (p = 6.76E-5, FDR = 0.14) and skeletal muscle tissue (p = 3.84E-5, FDR = 0.29). Here, ZNF235 is linked to amyotrophic lateral sclerosis.